Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L.

Emerg Infect Dis. 2009 Dec;15(12):2004-7. doi: 10.3201/eid1512.091413.

2.

Modelling mitigation strategies for pandemic (H1N1) 2009.

Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT.

CMAJ. 2009 Nov 10;181(10):673-80. doi: 10.1503/cmaj.091641. Epub 2009 Oct 13.

3.

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

JAMA. 2009 Nov 4;302(17):1872-9. doi: 10.1001/jama.2009.1496. Epub 2009 Oct 12.

PMID:
19822627
4.

The effect of universal influenza immunization on mortality and health care use.

Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, Johansen H, Sambell C, Thompson WW, Thiruchelvam D, Marra F, Svenson LW, Manuel DG.

PLoS Med. 2008 Oct 28;5(10):e211. doi: 10.1371/journal.pmed.0050211.

5.

The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.

Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR, Nicholson KG.

Vaccine. 2006 Feb 13;24(7):1035-43. Epub 2005 Sep 6.

PMID:
16183177
6.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT.

Drugs. 2002;62(7):1013-24. Review.

PMID:
11985488
7.

Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC.

Drugs Aging. 2000 Sep;17(3):217-27. Review.

PMID:
11043820
8.

Utility scores for chronic conditions in a community-dwelling population.

Mittmann N, Trakas K, Risebrough N, Liu BA.

Pharmacoeconomics. 1999 Apr;15(4):369-76.

PMID:
10537955

Supplemental Content

Support Center